Novartis AG
NVSEF · OTC
Bulios Fair Price
$147.44
3.8% upside
Current Price
$142.06
According to Bulios Fair Price, NVSEF is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Novartis AG is a Swiss multinational pharmaceutical company specializing in the development, manufacturing, and distribution of drugs and healthcare products. Founded in 1996 through the merger of Ciba-Geigy and Sandoz, the company is headquartered in Basel, Switzerland. Novartis focuses on treating a wide range of diseases, including cancer, cardiovascular conditions, neurological disorders, and more. The company is one of the largest global players in pharmaceutical research and development.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Vasant Narasimhan
Employees
75,267
Headquarters
Basel
Upcoming events
Earnings
Upcoming earnings report